Pfenex Reports Fourth Quarter and Full Year 2018 Results and Provides Business Update

Go back to Pfenex Reports Fourth Quarter and Full Year 2018 Results and Provides Business Update

Pfenex (PFNX) Tops Q4 EPS by 13c, Revenues Miss

March 11, 2019 4:21 PM EDT

Pfenex (NYSE: PFNX) reported Q4 EPS of ($0.22), $0.13 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $3.35 million versus the consensus estimate of $4.4 million.

We are excited about the opportunities before us in 2019 as we look to advance our key programs and expand our pipeline. This year we have multiple key milestones across our portfolio that hold the potential to transform Pfenex into a commercial stage... More